EuBiologics Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 0.00023 million compared to KRW 0.00014 million a year ago. Net loss was KRW 1,098.86 million compared to KRW 27,574.03 million a year ago.

Basic loss per share from continuing operations was KRW 30 compared to KRW 778 a year ago. Diluted loss per share from continuing operations was KRW 30 compared to KRW 778 a year ago. Basic loss per share was KRW 30 compared to KRW 778 a year ago.